ArticleRevista brasileira de enfermagem2025
Factors associated with death in severe patients with COVID-19/diabetes mellitus in Brazil.
Article in Revista brasileira de enfermagem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesto analyze factors associated with death in severe COVID-19/diabetes mellitus patients in Brazil.
methodsa cross-sectional study, carried out with notifications of severe respiratory diseases due to COVID-19 registered in the Brazilian Healthcare system database, between 2020 and 2022, Brazil. To analyze associated factors, univariate and multivariate logistic regression models were used.
resultsmales, aged 19 to 59 years, older adults, non-white race/skin color, low education level, nosocomial cases, Intensive Care Unit admission, ventilatory support, chronic cardiovascular and renal diseases, asthma, chronic lung diseases, immunosuppression, clinical manifestations, serological tests, and imaging were associated with a higher risk of death. Variables such as rural area, cough, sore throat, and antigen test not performed were protective factors.
conclusionsthese data reinforce the need for strategies based on social determinants of health to expand access, clinical management, and reduce mortality in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.